Dollinger index

Master International Franchising in China: Athlete’s Foot, Inc. 509 cants even came with large amounts of cash as testament to t ...

510 ENTREPRENEURSHIP CASE Antigua Argentina Aruba Australia Bahamas Barbados Canada Cayman Islands Chile China Costa Rica Curaca ...

Master International Franchising in China: Athlete’s Foot, Inc. 511 brands, such as Nike, Adidas and Reebok. The rest of the spo ...

512 ENTREPRENEURSHIP CASE address the radically changed demands of the marketplace. PA RT B In a quickly changing market, Rick W ...

Master International Franchising in China: Athlete’s Foot, Inc. 513 informed and powerful in this market as Wang had hoped. The ...

514 ENTREPRENEURSHIP CASE brand suppliers to commit, and the weak- nesses of The Athlete’s Foot as a franchisor. “If you want to ...

Biocon Ltd.: Building a Biotech Powerhouse 515 INTRODUCTION In November 2005, Biocon Ltd. was the largest biotechnology enterpri ...

516 ENTREPRENEURSHIP CASE Mazumdar-Shaw anticipated some sharp questions about the viability of expanding the company’s drug dis ...

Biocon Ltd.: Building a Biotech Powerhouse 517 and European markets. With $82-billion worth of global blockbusters facing patent ...

518 ENTREPRENEURSHIP CASE would not be a dependable employer. No banker was keen to talk to me across the table for a line of cr ...

Biocon Ltd.: Building a Biotech Powerhouse 519 shrink in value, it will continue to grow in volume. Biocon will differentiate it ...

520 ENTREPRENEURSHIP CASE Research. Syngene and Clinigene were already leading the research endeavors at Biocon, providing a val ...

Biocon Ltd.: Building a Biotech Powerhouse 521 Commercialization. Relative to the compa- ny’s other activities, Biocon had the l ...

522 ENTREPRENEURSHIP CASE Region United States Europe Canada Asia-Pacific Total No. of Listed Firms 330 98 82 131 641 No. of Pri ...

Biocon Ltd.: Building a Biotech Powerhouse 523 2005 $ million 2004 $ million EXHIBIT 3 India’s Major Biotech Firms, Ranked by Bi ...

524 ENTREPRENEURSHIP CASE 2005 148.18 15.18 3.46 166.82 89.72 7.70 69.40 3.36 10.91 5.04 0.44 5.67 43.98 0.45 49.79 0.23 41.83 1 ...

Biocon Ltd.: Building a Biotech Powerhouse 525 Amylases Cellulases Esterases Glucanases Hemicellulases Xylanases Oxidases Pectin ...

526 ENTREPRENEURSHIP CASE SOURCE: Joel Ruet et al., Biotechnology in India, Les biotechnologies en Inde, 2001, http://www.cerna. ...

Biocon Ltd.: Building a Biotech Powerhouse 527 Target identificationDrugs usually act on chemicals in the body—known as targets ...

agers of the firm. He had a solid track record but the technology and venture capital mar- kets had been so painful over the pas ...